Sonavex

Another week, another new site enrolling in the?#Sonavex?#MAFASA clinical trial.?Looking forward to a great year with the?Capital Health (US) team. Special thanks to Dr Christine Lotto, Dr Jillian Walsh and Lisa Gant for their support. #EmpoweredPatientCare

A huge thanks to Dr. Sagar Gandhi, and the team at Prisma Health for partnering with us on the MAFASA trial. Congratulations to them for their first enrollment earlier this week. A terrific team to work with! #Sonavex #MAFASA #EmpoweredPatientCare

As we close out 2024, Sonavex is grateful for our research sites and their patients for partnering with us on our MAFASA Trial! Tremendous progress to date provides fuel for what will be an exciting 2025! Special thanks to our fantastic group of investigators and their dedicated research teams. Rounding out enrollment in 2024, here's a photo of the team at Northwell Health after enrolling their first subject. Happy New Year to all!!! #MAFASA #EmpoweredPatientCare

Great collaboration with the team at Orlando Health and Mohammad Abbasi ! Looking forward to a strong 2025.

Thank you to Mohammad Abbasi and the talented research team at Orlando Health for partnering with us on the MAFASA clinical trial. Congratulations to them on their first enrollment last week. Excellent team!

We’re looking forward to attending the 51st annual VEITH Symposium! An excellent meeting on all things vascular. If you’re curious to hear more about our MAFASA trial on vascular accesses, please reach out. #VEITHsymposium #Vascular #MAFASA #EmpoweredPatientCare

Thanks to Dr.?Mark?London, Faren Stroman NP?and the excellent team at MUSC Health Dialysis Access Institute for partnering with Sonavex on the MAFASA clinical trial.?Congratulations?to them for their first enrollment last week. Incredible to work with a team committed to improving outcomes for dialysis access patients. #MAFASA #EmpoweredPatientCare

Exciting news for Sonavex! We’re proud to announce that EchoMark & EchoSure have been selected as part of TIME’s Best Inventions of 2024. ? While fistulas are the preferred method for hemodialysis access, many patients rely on central venous catheters for an extended duration, which can lead to many detrimental health outcomes. The EchoMark & EchoSure System allows for accurate fistula assessments in the dialysis clinic to expedite their use, reducing the reliance on catheters. ? This honor highlights the important impact our solution can have on dialysis patients. ? To learn more about our novel ultrasound system and see the full list of TIME’s best inventions, visit the website here:?https://lnkd.in/ePuvQdXt ? #TIMEBestInvention #Sonavex #EmpoweredPatientCare

We are thrilled to announce the closing of our $15M Series A-2 financing. A portion of the proceeds will support our 304-patient “MAFASA” clinical trial?for EchoMark & EchoSure.? ? The funding comes on the heels of recent milestones including strong clinical data, a new CPT code, FDA IDE approval for the MAFASA pivotal trial, and grant funding to support the advancement of EchoGuide.? ? Read more about it here: https://lnkd.in/ePrttCMZ

Sonavex is pleased to announce the publication of new data demonstrating the feasibility and accuracy of EchoMark & EchoSure for AV fistula maturation assessment in the Journal of Vascular Access. Shout out to Dr. Lannery Lauvao, Dr. Jason Burgess, and Dr. Jason Beaver for your dedication and support. Check out the article here: https://lnkd.in/eDm9fdze #EmpoweredPatientCare